Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Cancer Causes Control. 2008 May 14;19(9):975–980. doi: 10.1007/s10552-008-9164-3

Table 2.

Association of TCF7L2 variants with covariates

Cases
N (%)
Controls
N (%)
Multivariate OR1
(95% CI)
P-int2
TCF7L2 Family History
GG No 152 (42.9) 335 (41.9) 1.00 (Ref)
GT+TT No 120 (33.9) 334 (41.8) 0.78 (0.58 – 1.06)
GG Yes 45 (12.7) 70 (8.8) 1.35 (0.85 – 2.13)
GT+TT Yes 37 (10.4) 61 (7.6) 1.39 (0.85 – 2.27)
0.45
TCF7L2 BMI
GG <25 85 (24.0) 185 (23.3) 1.00 (Ref)
GT+TT <25 69 (19.5) 190 (23.8) 0.83 (0.55 – 1.24)
GG ≥25 112 (31.6) 220 (27.5) 1.02 (0.70 – 1.50)
GT+TT ≥25 88 (24.9) 205 (25.6) 0.84 (0.55 – 1.24) 0.27
1

Logistic regression adjusted for family history of colon cancer, pack years smoked, body mass index (BMI), post-menopausal hormone (PMH) use, aspirin intake, physical activity, alcohol intake, total folate consumption, and red meat consumption.

2

P-int: p-values obtained from the likelihood ratio test (LRT) comparing models with and without the interaction term between genotype and covariate